Avalere: Plans Putting Generics On High-Cost Tiers To Offset Rising Brand Prices

By John Wilkerson / May 22, 2018 at 2:54 PM
Generic drug costs are rising for seniors in Part D, even though prices for the drugs remain flat, because plans are putting generics on higher formulary tiers, according to an Avalere analysis. The report states that plans are placing generics on higher-cost tiers to offset rising prices for brand drugs. “The number of generic prescription drugs placed on the lowest tier, where patients pay less for their drugs, declined 53 percentage points between 2011 and 2015,” Avalere reports. “This shift...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.